Amarin Corporation
AMRN
#7761
Rank
โ‚น30.91 B
Marketcap
โ‚น1,487
Share price
0.49%
Change (1 day)
75.62%
Change (1 year)

Revenue for Amarin Corporation (AMRN)

Revenue in 2025 (TTM): โ‚น19.58 Billion

According to Amarin Corporation 's latest financial reports the company's current revenue (TTM ) is โ‚น20.38 Billion. In 2024 the company made a revenue of โ‚น19.61 Billion a decrease over the revenue in the year 2023 that were of โ‚น25.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amarin Corporation from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น19.58 B-0.14%
2024 โ‚น19.61 B-23.24%
2023 โ‚น25.54 B-16.37%
2022 โ‚น30.55 B-29.62%
2021 โ‚น43.40 B-3.34%
2020 โ‚น44.90 B46.54%
2019 โ‚น30.64 B91.21%
2018 โ‚น16.02 B38.6%
2017 โ‚น11.56 B30.81%
2016 โ‚น8.83 B62.7%
2015 โ‚น5.43 B58.16%
2014 โ‚น3.43 B111.02%
2013 โ‚น1.62 B
2012 N/A
2011 N/A
2010 N/A
2003 -โ‚น0.69 Billion-121.78%
2002 โ‚น3.14 B21.07%
2001 โ‚น2.59 B213.45%
2000 โ‚น0.82 B
1998 โ‚น0.80 B-14.44%
1997 โ‚น0.93 B15.1%
1996 โ‚น0.81 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
โ‚น5.361 T 26,205.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.225 T 25,536.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
โ‚น136.76 B 570.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
GlaxoSmithKline
GSK
โ‚น3.807 T 18,579.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น1.508 T 7,298.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel